niacinamide has been researched along with Cancer of the Tongue in 1 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jones, SJ | 1 |
| Laskin, J | 1 |
| Li, YY | 1 |
| Griffith, OL | 1 |
| An, J | 1 |
| Bilenky, M | 1 |
| Butterfield, YS | 1 |
| Cezard, T | 1 |
| Chuah, E | 1 |
| Corbett, R | 1 |
| Fejes, AP | 1 |
| Griffith, M | 1 |
| Yee, J | 1 |
| Martin, M | 1 |
| Mayo, M | 1 |
| Melnyk, N | 1 |
| Morin, RD | 1 |
| Pugh, TJ | 1 |
| Severson, T | 1 |
| Shah, SP | 1 |
| Sutcliffe, M | 1 |
| Tam, A | 1 |
| Terry, J | 1 |
| Thiessen, N | 1 |
| Thomson, T | 1 |
| Varhol, R | 1 |
| Zeng, T | 1 |
| Zhao, Y | 1 |
| Moore, RA | 1 |
| Huntsman, DG | 1 |
| Birol, I | 1 |
| Hirst, M | 1 |
| Holt, RA | 1 |
| Marra, MA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Personalized OncoGenomics (POG) Program of British Columbia: Connecting Cancer Genomics to Cancer Care[NCT02155621] | 5,000 participants (Anticipated) | Interventional | 2014-07-31 | Recruiting | |||
| Canadian Atezolizumab Precision Targeting for Immunotherapy Intervention[NCT04273061] | Phase 2 | 200 participants (Anticipated) | Interventional | 2020-06-17 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for niacinamide and Cancer of the Tongue
| Article | Year |
|---|---|
Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors.
Topics: Adenocarcinoma; Benzenesulfonates; Gene Dosage; Gene Expression Regulation, Neoplastic; Genes, Neopl | 2010 |
Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors.
Topics: Adenocarcinoma; Benzenesulfonates; Gene Dosage; Gene Expression Regulation, Neoplastic; Genes, Neopl | 2010 |
Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors.
Topics: Adenocarcinoma; Benzenesulfonates; Gene Dosage; Gene Expression Regulation, Neoplastic; Genes, Neopl | 2010 |
Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors.
Topics: Adenocarcinoma; Benzenesulfonates; Gene Dosage; Gene Expression Regulation, Neoplastic; Genes, Neopl | 2010 |